{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:10:25Z","timestamp":1791954625727,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>The posttransplant outcomes and optimal management of patients with end-stage liver disease who develop cryptococcosis prior to transplantation have not been defined. We discuss these issues in the context of successful liver transplantation and pretransplant cryptococcal disease. Our report suggests that liver transplantation may be cautiously considered under the umbrella of fluconazole therapy in patients with end-stage liver disease and pretransplant cryptococcosis, provided that disease control is achieved with adequate treatment before transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22024","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T15:42:25Z","timestamp":1264088545000},"page":"499-502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Pretransplant cryptococcosis and outcome after liver transplantation"],"prefix":"10.1097","volume":"16","author":[{"given":"Costi D.","family":"Sifri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Cacciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wispelwey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Pruett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20250326","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000126760.45299.69","article-title":"Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates.","volume":"83","author":"Singh","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R2-15-20250326","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: clinical features and prognostic factors.","volume":"95","author":"Jean","year":"2002","journal-title":"QJM"},{"key":"R3-15-20250326","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-007-0430-1","article-title":"Disseminated cryptococcosis in HIV-uninfected patients.","volume":"27","author":"Chuang","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R4-15-20250326","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science.","volume":"47","author":"Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R5-15-20250326","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/JCM.37.10.3204-3209.1999","article-title":"Epidemiological evidence for dormant Cryptococcus neoformans infection.","volume":"37","author":"Garcia-Hermoso","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R6-15-20250326","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/ajcp\/24.12.1381","article-title":"The pulmonary lesions in cryptococcosis with special reference to subpleural nodules.","volume":"24","author":"Haugen","year":"1954","journal-title":"Am J Clin Pathol"},{"key":"R7-15-20250326","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinids\/21.5.1077","article-title":"Infections in liver transplant recipients.","volume":"21","author":"Winston","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R8-15-20250326","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect Immun"},{"key":"R9-15-20250326","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1128\/IAI.00176-07","article-title":"Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector.","volume":"75","author":"Milam","year":"2007","journal-title":"Infect Immun"},{"key":"R10-15-20250326","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1348-0421.1995.tb02180.x","article-title":"T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection.","volume":"39","author":"Kawakami","year":"1995","journal-title":"Microbiol Immunol"},{"key":"R11-15-20250326","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.142.9.3219","article-title":"Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.","volume":"142","author":"Flesch","year":"1989","journal-title":"J Immunol"},{"key":"R12-15-20250326","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.179.8.5367","article-title":"IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.","volume":"179","author":"Muller","year":"2007","journal-title":"J Immunol"},{"key":"R13-15-20250326","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1165\/rcmb.2003-0156OC","article-title":"Role of interleukin-4 in resistance to Cryptococcus neoformans infection.","volume":"30","author":"Blackstock","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R14-15-20250326","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","article-title":"Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.","volume":"66","author":"Decken","year":"1998","journal-title":"Infect Immun"},{"key":"R15-15-20250326","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cimm.1999.1557","article-title":"Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.","volume":"197","author":"Kawakami","year":"1999","journal-title":"Cell Immunol"},{"key":"R16-15-20250326","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOT.0b013e32831b70c2","article-title":"Relative roles of Th1 and Th17 effector cells in allograft rejection.","volume":"14","author":"Atalar","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R17-15-20250326","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R18-15-20250326","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0952-7915(96)80087-2","article-title":"The Th1Th2 paradigm and the allograft response.","volume":"8","author":"Strom","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"R19-15-20250326","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/595006","article-title":"HIVAIDS: immune reconstitution inflammatory syndrome: a reappraisal.","volume":"48","author":"French","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R20-15-20250326","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-15-20250326","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-3062.2006.00149.x","article-title":"Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab.","volume":"9","author":"Silveira","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R22-15-20250326","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1592\/phco.26.12.1730","article-title":"Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.","volume":"26","author":"Saad","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R23-15-20250326","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/00007890-200211270-00024","article-title":"Fluconazole-sirolimus drug interaction.","volume":"74","author":"Cervelli","year":"2002","journal-title":"Transplantation"},{"key":"R24-15-20250326","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.transproceed.2004.10.056","article-title":"Clinical relevance of sirolimus drug interactions in transplant patients.","volume":"36","author":"Sadaba","year":"2004","journal-title":"Transplant Proc"},{"key":"R25-15-20250326","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1345\/aph.1L330","article-title":"Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.","volume":"42","author":"Pea","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R26-15-20250326","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-3476(78)80433-8","article-title":"Successful renal transplantation after generalized cryptococcosis.","volume":"92","author":"Iitaka","year":"1978","journal-title":"J Pediatr"},{"key":"R27-15-20250326","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00000658-197511000-00014","article-title":"The incidence and management of pulmonary mycosis in renal allograft patients.","volume":"182","author":"Mills","year":"1975","journal-title":"Ann Surg"},{"key":"R28-15-20250326","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archinte.1969.00300200114019","article-title":"Successful renal allograft in a patient with pulmonary cryptococcus.","volume":"124","author":"Swenson","year":"1969","journal-title":"Arch Intern Med"},{"key":"R31-15-20250326","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22024","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201004000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:24:26Z","timestamp":1743265466000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201004000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22024","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}